Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells.

Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells.
复制标题

DOI:
10.1016/j.yexcr.2013.04.006
复制
发表时间:
2013-06-10
影响因子:
3.7
通讯作者:
Gudas, Lorraine J.
Gudas, Lorraine J.
中科院分区:
医学3区
文献类型:
--
作者:
Benoit, Yannick D.;Witherspoon, Mavee S.;Laursen, Kristian B.;Guezguez, Amel;Beausejour, Marco;Beaulieu, Jean-Francois;Lipkin, Steven M.;Gudas, Lorraine J.

文献摘要

参考文献

被引文献

相似文献

结直肠癌是美国癌症死亡的主要原因之一。多梳抑制复合物2(PRC2),包括核心组分SUZ12和EZH2,代表了消化上皮细胞生理学的关键表观遗传调节因子,并且先前显示在许多人类癌症(包括结肠癌)中促进有害作用。使用从人原发性结直肠肿瘤中分离的结肠癌干细胞(CCSC),我们证明SUZ12敲低和用最有效的EZH2抑制剂之一DZNep处理增加了CCSC中的凋亡水平,其标志是Akt磷酸化降低,而胚胎干细胞(ES)存活不受影响。此外,DZNep治疗导致这些高度致瘤性细胞中的PTEN表达增加。综上所述,我们的研究结果表明,PRC2组蛋白甲基转移酶活性的药理学抑制可能构成一种新的表观遗传治疗策略,以靶向高度致瘤性和转移性结肠癌干细胞。
Colorectal cancer is among the leading causes of cancer death in the USA. The polycomb repressive complex 2 (PRC2), including core components SUZ12 and EZH2, represents a key epigenetic regulator of digestive epithelial cell physiology and was previously shown to promote deleterious effects in a number of human cancers, including colon. Using colon cancer stem cells (CCSC) isolated from human primary colorectal tumors, we demonstrate that SUZ12 knockdown and treatment with DZNep, one of the most potent EZH2 inhibitors, increase apoptosis levels, marked by decreased Akt phosphorylation, in CCSCs, while embryonic stem (ES) cell survival is not affected. Moreover, DZNep treatments lead to increased PTEN expression in these highly tumorigenic cells. Taken together, our findings suggest that pharmacological inhibition of PRC2 histone methyltransferase activity may constitute a new, epigenetic therapeutic strategy to target highly tumorigenic and metastatic colon cancer stem cells.
DOI: 10.1158/0008-5472.can-08-4418
发表时间: 2009-04-15
期刊: Cancer research
影响因子: 11.2
作者:
Huang EH;Hynes MJ;Zhang T;Ginestier C;Dontu G;Appelman H;Fields JZ;Wicha MS;Boman BM
通讯作者: Boman BM
DOI: 10.1186/1476-4598-9-192
发表时间: 2010-07-14
期刊: Molecular cancer
影响因子: 37.3
作者:
Botchkina GI;Zuniga ES;Das M;Wang Y;Wang H;Zhu S;Savitt AG;Rowehl RA;Leyfman Y;Ju J;Shroyer K;Ojima I
通讯作者: Ojima I
DOI: 10.1155/2012/248759
发表时间: 2012
期刊: Journal of signal transduction
影响因子: --
作者:
Benoit YD;Groulx JF;Gagné D;Beaulieu JF
通讯作者: Beaulieu JF
DOI: 10.1242/jcs.102061
发表时间: 2012-07-15
影响因子: 4
作者:
Benoit, Yannick D.;Lepage, Manon B.;Beaulieu, Jean-Francois
通讯作者: Beaulieu, Jean-Francois
DOI: 10.1002/jcp.24145
发表时间: 2013-02-01
影响因子: 5.6
作者:
Bellizzi, Antonia;Sebastian, Sinto;Paradiso, Angelo
通讯作者: Paradiso, Angelo